Neogermidine

Catalog No. :
ACDHCF702
CAS No. :
560-49-6
Molecular Formula :
C34H53NO10
Molecular Weight :
635.79

IUPAC Name:(3S,4S,4aS,6R,6aS,6bS,7S,8R,8aR,9S,9aS,12S,15aS,15bS,16aR,16bS)-6-acetoxy-3,4,6b,8,9-pentahydroxy-9,12,16b-trimethyldocosahydro-2H-4,16a-epoxybenzo[4,5]indeno[1,2-h]pyrido[1,2-b]isoquinolin-7-yl (R)-2-methylbutanoate

Neogermidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameNeogermidine
IUPAC Name(3S,4S,4aS,6R,6aS,6bS,7S,8R,8aR,9S,9aS,12S,15aS,15bS,16aR,16bS)-6-acetoxy-3,4,6b,8,9-pentahydroxy-9,12,16b-trimethyldocosahydro-2H-4,16a-epoxybenzo[4,5]indeno[1,2-h]pyrido[1,2-b]isoquinolin-7-yl (R)-2-methylbutanoate
Molecular FormulaC34H53NO10
Molecular Weight635.79
SMILESCC[C@@H](C)C(=O)O[C@H]1[C@H](O)[C@H]2[C@@H](CN3C[C@@H](C)CC[C@H]3[C@@]2(C)O)[C@@H]2C[C@@]34O[C@@]5(O)[C@@H](C[C@@H](OC(C)=O)[C@H]3[C@@]21O)[C@]4(C)CC[C@@H]5O
InChI KeyCDTUWAZCNSYUTG-ZUNZDKPLSA-N
Synonym4α,9-Epoxycevane-3β,4,7α,14,15α,16β,20-heptol 7-acetate 15-[(R)-2-methylbutanoate];Isogermidine;Neogermidine;Cevane-3,4,7,14,15,16,20-heptol, 4,9-epoxy-, 7-acetate 15-[(2R)-2-methylbutanoate], (3β,4α,7α,15α,16β)- (9CI)
CAS No.560-49-6

Synthetic Route by SureRoute

1. ACDHCF702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDUBI165 route compound structure diagram
    ACDUBI1654033-83-4 In Stock
  4. Then
  5. ACDHCF702 route product structure diagram
    ACDHCF702560-49-6
Inquiry

2. ACDHCF702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDHCF702 route product structure diagram
    ACDHCF702560-49-6
Inquiry

Comments (0)